Dr Melissa C Knutson, DO | |
1351 Ronald Reagan Pkwy Ste A, Avon, IN 46123-6764 | |
(317) 217-2919 | |
(317) 217-2916 |
Full Name | Dr Melissa C Knutson |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 17 Years |
Location | 1351 Ronald Reagan Pkwy Ste A, Avon, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578721783 | NPI | - | NPPES |
201032610 | Medicaid | IN | |
000000729675 | Other | IN | ANTHEM PIN |
Facility Name | Location | Facility Type |
---|---|---|
Preferred Home Health Care, Inc | Indianapolis, IN | Home health agency |
Elara Caring | Kokomo, IN | Home health agency |
Indiana University Health Hospice | Indianapolis, IN | Hospice |
Iu Health West Hospital | Avon, IN | Hospital |
Indiana University Health | Indianapolis, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Indiana University Health Care Associates Inc | 5799755864 | 882 |
News Archive
Specialist antenatal clinics for severely obese mums-to-be can help cut rates of pregnancy complications, research has found.
CSL Biotherapies welcomed news overnight of a decision by the World Health Assembly to adopt the Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits.
The U.S. Food and Drug Administration today approved raxibacumab injection to treat inhalational anthrax, a form of the infectious disease caused by breathing in the spores of the bacterium Bacillus anthracis. Raxibacumab also is approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the United States Food and Drug Administration informed CTI that due to severe weather conditions in the Washington, D.C. area, the FDA is postponing the Oncologic Drugs Advisory Committee ("ODAC") meeting that was to be held on Wednesday, February 10, 2010 to discuss the pixantrone New Drug Application ("NDA"). The FDA indicated that it intends to reschedule the meeting as soon as the FDA can determine a schedule that will allow them to reconvene the advisory panel.
Bend Memorial Clinic (BMC), the largest provider of quality, comprehensive and convenient physician healthcare in Central Oregon, has joined with Clear One Health Plans to offer the region's first Focused Patient Care Model, similar to a Medical Home Model, beginning January 1, 2010. BMC's team of more than 100 physicians and other providers care for approximately 3,800 Clear One Medicare Advantage members all of whom will qualify for the program.
› Verified 2 days ago
Entity Name | Indiana University Health Care Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902032832 PECOS PAC ID: 5799755864 Enrollment ID: O20040727000955 |
News Archive
Specialist antenatal clinics for severely obese mums-to-be can help cut rates of pregnancy complications, research has found.
CSL Biotherapies welcomed news overnight of a decision by the World Health Assembly to adopt the Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits.
The U.S. Food and Drug Administration today approved raxibacumab injection to treat inhalational anthrax, a form of the infectious disease caused by breathing in the spores of the bacterium Bacillus anthracis. Raxibacumab also is approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the United States Food and Drug Administration informed CTI that due to severe weather conditions in the Washington, D.C. area, the FDA is postponing the Oncologic Drugs Advisory Committee ("ODAC") meeting that was to be held on Wednesday, February 10, 2010 to discuss the pixantrone New Drug Application ("NDA"). The FDA indicated that it intends to reschedule the meeting as soon as the FDA can determine a schedule that will allow them to reconvene the advisory panel.
Bend Memorial Clinic (BMC), the largest provider of quality, comprehensive and convenient physician healthcare in Central Oregon, has joined with Clear One Health Plans to offer the region's first Focused Patient Care Model, similar to a Medical Home Model, beginning January 1, 2010. BMC's team of more than 100 physicians and other providers care for approximately 3,800 Clear One Medicare Advantage members all of whom will qualify for the program.
› Verified 2 days ago
Entity Name | Indiana Clinic Critical Care Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417285230 PECOS PAC ID: 3678600988 Enrollment ID: O20100419000408 |
News Archive
Specialist antenatal clinics for severely obese mums-to-be can help cut rates of pregnancy complications, research has found.
CSL Biotherapies welcomed news overnight of a decision by the World Health Assembly to adopt the Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits.
The U.S. Food and Drug Administration today approved raxibacumab injection to treat inhalational anthrax, a form of the infectious disease caused by breathing in the spores of the bacterium Bacillus anthracis. Raxibacumab also is approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the United States Food and Drug Administration informed CTI that due to severe weather conditions in the Washington, D.C. area, the FDA is postponing the Oncologic Drugs Advisory Committee ("ODAC") meeting that was to be held on Wednesday, February 10, 2010 to discuss the pixantrone New Drug Application ("NDA"). The FDA indicated that it intends to reschedule the meeting as soon as the FDA can determine a schedule that will allow them to reconvene the advisory panel.
Bend Memorial Clinic (BMC), the largest provider of quality, comprehensive and convenient physician healthcare in Central Oregon, has joined with Clear One Health Plans to offer the region's first Focused Patient Care Model, similar to a Medical Home Model, beginning January 1, 2010. BMC's team of more than 100 physicians and other providers care for approximately 3,800 Clear One Medicare Advantage members all of whom will qualify for the program.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Melissa C Knutson, DO 250 N Shadeland Ave, Ste 130 Provider Enrollment, Indianapolis, IN 46219-4959 Ph: () - | Dr Melissa C Knutson, DO 1351 Ronald Reagan Pkwy Ste A, Avon, IN 46123-6764 Ph: (317) 217-2919 |
News Archive
Specialist antenatal clinics for severely obese mums-to-be can help cut rates of pregnancy complications, research has found.
CSL Biotherapies welcomed news overnight of a decision by the World Health Assembly to adopt the Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits.
The U.S. Food and Drug Administration today approved raxibacumab injection to treat inhalational anthrax, a form of the infectious disease caused by breathing in the spores of the bacterium Bacillus anthracis. Raxibacumab also is approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the United States Food and Drug Administration informed CTI that due to severe weather conditions in the Washington, D.C. area, the FDA is postponing the Oncologic Drugs Advisory Committee ("ODAC") meeting that was to be held on Wednesday, February 10, 2010 to discuss the pixantrone New Drug Application ("NDA"). The FDA indicated that it intends to reschedule the meeting as soon as the FDA can determine a schedule that will allow them to reconvene the advisory panel.
Bend Memorial Clinic (BMC), the largest provider of quality, comprehensive and convenient physician healthcare in Central Oregon, has joined with Clear One Health Plans to offer the region's first Focused Patient Care Model, similar to a Medical Home Model, beginning January 1, 2010. BMC's team of more than 100 physicians and other providers care for approximately 3,800 Clear One Medicare Advantage members all of whom will qualify for the program.
› Verified 2 days ago
Bhasker Reddy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1115 N Ronald Reagan Parkway, Suite 206, Avon, IN 46123 Phone: 317-272-8050 Fax: 317-272-8051 | |
Namrata Shah, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 Ronald Reagan Pkwy Ste B1500, Avon, IN 46123 Phone: 317-217-2244 Fax: 317-217-2249 | |
Graham D Dellinger, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 317-217-2888 Fax: 317-217-2999 | |
Caitlin M Baxter, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 317-962-5820 Fax: 317-962-3916 | |
Dr. Stephen H Pollom, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1115 Ronald Reagan Pkwy, Ste 318, Avon, IN 46123 Phone: 317-217-2600 Fax: 317-217-2606 | |
Dr. David Lee Hyslop, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6013 Yellow Birch Ct, Avon, IN 46123 Phone: 317-838-7096 | |
Michaela A Besold, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8244 E Us Highway 36, Suite 1320, Avon, IN 46123 Phone: 317-272-7519 Fax: 317-272-3661 |